Discover Great Companies Discover Great Clients
Popularity  2.4万   |   Followers  8   |   Likes  21   |   Feedback  5 Claim this company

Innovation-driven biopharmaceutical company

Shanghai Pudong New Area No.17 Dan Bai Yao Products No.22 Culture Media No.22 CMC No.27 Lin Chuang Yong Yao No.27 Suo Jia Ji Xian Wei Su Sodium No.27 Suo Jia Ji Xian Wei Su No.30 Dan Ke Long Kang Ti Yan Jiu No.34 Zhu She Liquids No.35 GMP Production No.36 Dan Ke Long Kang Ti Yao Products No.45 Dan Ke Long Kang Ti Antibodies 省级高新技术企业 市级高新技术企业
More

Company Overview

  • Nature: Joint Venture Size: 100-499 employees Founded: 19年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Genor Biopharma Co., Ltd.。

Development Stage

  • Stage: 战略投资。
  • Honors: 省级高新技术企业 市级高新技术企业 According to algorithm
  • News: 2020-09-14:生物制药公司嘉和生物通过港交所聆讯。

About the Company

[Summary] Innovation-driven biopharmaceutical company

Rooted in China, laying out globally, an innovation-driven biopharmaceutical company - Genor Biopharma (Stock Code: 6998.HK) is committed to building a full value chain of biopharmaceutical innovation: a powerful dual/multi-specific antibody R&D platform adopts computer-aided technology for the development and optimization of significantly differentiated dual-target and multi-target monoclonal antibodies; the CMC process technology R&D center possesses internationally advanced process development capabilities, preclinical and clinical drug production capabilities, strong analytical testing capabilities, and a comprehensive quality system; the commercial GMP production base has continuous perfusion high-expression (20g/L), self-developed culture media, cost-effective commercial production capabilities, and a technical team highly compliant with GMP regulations. Among more than ten products of Genor Biopharma in clinical trials or regulatory filing stages, Geptanolimab Injection is planned to achieve commercialization in 2021, bringing therapeutic benefits to patients as a PD-1 product for peripheral T-cell lymphoma indications.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Genor Biopharma Financing History (1 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 金晟资产,融汇资本

Genor Biopharma honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 5,000万(元)
Legal Representative: GUO FENG(郭峰)
Date Established:
Credit Code: 913100006693667767
Registered Address: 中国(上海)自由贸易试验区碧波路690号6幢501-02室

Partners & Suppliers

提供生物类似药及创新抗体药学研究 Source
供应商 生物药研发企业
采购其生物分离纯化介质(层析填料) Source
供应商 生物制药
嘉和生物委托碧博生物进行抗体类药物生产,双方签署战略合作框架协议。 Source
供应商 生物药CDMO服务

People who follow Genor Biopharma also follow

Genor Biopharma Competitors (Similar Companies)

“One of the leading enterprises in the pharmaceutical industry”
临床试验 康复 医疗科技 临床研究
“原创药物研发企业”
“SaaS service provider for technology innovation intelligence”
“A marine engineering contractor and equipment manufacturer specialized”
“A clinical-stage AI-driven innovative drug R&D company”
医药 抗体 药物研发 研发
生物科技/生物工程 药物研发 生物实验 新药研发
“miRNA 技术平台”
“Research, development, and production of anti-tumor and surgical medic”
“Let people share the health and happiness brought by technology”
生物科技/生物工程 医药 基因合成 生物医药

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Pudong New Area”公司名录 上海“制药/药业”公司名录 上海“药物研发”公司名录 上海“生物制药”公司名录 上海“单克隆抗体药物”公司名录 上海“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates